🇺🇸 FDA
Patent

US 8128924

Methods for using a three-dimensional stromal tissue to promote angiogenesis

granted A61PA61P41/00A61P43/00

Quick answer

US patent 8128924 (Methods for using a three-dimensional stromal tissue to promote angiogenesis) held by Theregen, Inc. expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theregen, Inc.
Grant date
Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P41/00, A61P43/00, A61P9/10